BioRestorative spikes on talks for a potential licensing pact

seekingalpha06-13

BioRestorative Therapies (NASDAQ:BRTX) traded ~20% higher in the premarket Thursday after the New York-based biotech said it has engaged in talks with a commercial-stage company to license IP rights ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2443683328?lang=en_US&edition=fundamental","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1148889142/image_1148889142.jpg","is_english":true,"pubTime":"2024-06-13 20:01","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"2443683328","market":"sh","top_or_hot":-1,"title":"BioRestorative spikes on talks for a potential licensing pact","media":"seekingalpha","content":"<div>\n<p>BioRestorative Therapies (NASDAQ:BRTX) traded ~20% higher in the premarket Thursday after the New York-based biotech said it has engaged in talks with a commercial-stage company to license IP rights ...</p>\n\n<a href=\"https://seekingalpha.com/news/4115497-biorestorative-stock-spikes-licensing-talks\">Source Link</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BioRestorative spikes on talks for a potential licensing pact</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBioRestorative spikes on talks for a potential licensing pact\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-06-13 20:01 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/4115497-biorestorative-stock-spikes-licensing-talks><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>BioRestorative Therapies (NASDAQ:BRTX) traded ~20% higher in the premarket Thursday after the New York-based biotech said it has engaged in talks with a commercial-stage company to license IP rights ...</p>\n\n<a href=\"https://seekingalpha.com/news/4115497-biorestorative-stock-spikes-licensing-talks\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BRTX","symbol_name":"BioRestorative Therapies, Inc.","start_time":0,"source_url":"https://seekingalpha.com/news/4115497-biorestorative-stock-spikes-licensing-talks","article_id":"2443683328","we_media_id":null,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1148889142/image_1148889142.jpg"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2443683328","pubTimestamp":1718280099,"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"BioRestorative Therapies  traded ~20% higher in the premarket Thursday after the New York-based biotech said it has engaged in talks with a commercial-stage company to license IP rights related to its ThermoStem platform. Without naming its potential partner, BioRestorative  said that the company held “substantive” discussions with a commercial-stage regenerative medicine company for a possible deal,  ThermoStem represents BioRestorative’s  metabolic program, designed to develop cell therapy candidates based on brown adipose - derived stem cells . Studies have shown the potential of BADSCs in treating obesity and related metabolic disorders. “It has been captivating to watch the scale, scope, and speed with which potential license partners have begun to show interest in our proprietary off-the-shelf ThermoStem platform,” said Lance Alstodt, BRTX’s CEO.","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BRTX":"BioRestorative Therapies, Inc.","BK4139":"生物科技"},"translate_title":"生物修复公司因潜在许可协议谈判而飙升","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BRTX":1},"content_text":"BioRestorative Therapies (NASDAQ:BRTX) traded ~20% higher in the premarket Thursday after the New York-based biotech said it has engaged in talks with a commercial-stage company to license IP rights related to its ThermoStem platform. Without naming its potential partner, BioRestorative (BRTX) said that the company held “substantive” discussions with a commercial-stage regenerative medicine company for a possible deal,  ThermoStem represents BioRestorative’s (BRTX) metabolic program, designed to develop cell therapy candidates based on brown adipose (fat)- derived stem cells (BADSCs). Studies have shown the potential of BADSCs in treating obesity and related metabolic disorders. “It has been captivating to watch the scale, scope, and speed with which potential license partners have begun to show interest in our proprietary off-the-shelf ThermoStem® platform,” said Lance Alstodt, BRTX’s CEO.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.24.2","shortVersion":"4.24.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2443683328"}